Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Microbes Infect. 2014 Aug 11;16(9):762–767. doi: 10.1016/j.micinf.2014.07.009

Fig. 1. The prophylactic antibacterial activity of hLF against S. mutans-induced bacteremia in LFKO−/− mice.

Fig. 1

Experimental groups (n=5–8) were i.v. injected hLF and S. mutans to induce bacteremia. The number of bacteria from blood and different organs are expressed as ±SEM mean CFU/ml blood or CFU/g of tissue-wet weight, respectively. The hLF bioavailability was assessed by ELISA in duplicate experiments for each mouse. Asterisks indicate statistical significance (P<0.05) of differences between the groups (◆-S. mutans alone i.v. injected; ■-hLF prophylactic treatment), as calculated by the ANOVA. The data shown are from the mean of triplicate experiments (±SEM).